chr1-25618219-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020379.4(MAN1C1):āc.422T>Cā(p.Phe141Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000438 in 1,597,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020379.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAN1C1 | NM_020379.4 | c.422T>C | p.Phe141Ser | missense_variant | 1/12 | ENST00000374332.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAN1C1 | ENST00000374332.9 | c.422T>C | p.Phe141Ser | missense_variant | 1/12 | 1 | NM_020379.4 | P1 | |
MAN1C1 | ENST00000263979.7 | c.-244T>C | 5_prime_UTR_variant | 1/13 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000465 AC: 1AN: 215144Hom.: 0 AF XY: 0.00000844 AC XY: 1AN XY: 118484
GnomAD4 exome AF: 0.00000346 AC: 5AN: 1445758Hom.: 0 Cov.: 31 AF XY: 0.00000278 AC XY: 2AN XY: 718162
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.422T>C (p.F141S) alteration is located in exon 1 (coding exon 1) of the MAN1C1 gene. This alteration results from a T to C substitution at nucleotide position 422, causing the phenylalanine (F) at amino acid position 141 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at